A second Trump Administration might mean deregulation and more permitted transactions for the banking industry. Many, but not all, agency priorities may also change significantly. While the coming ...

The World Health Organization ("WHO") published key principles for regulating artificial intelligence (AI) for health on 19 October 2023. The document, titled ‘Regulatory Considerations on Artificial ...

Clinical trials are undergoing a fundamental shift as emerging technologies reshape how studies are designed, executed and ...

Valensi Rose PLC provides the following overview of the deconstruction process and a general discussion of the potential federal charitable contribution tax considerations associated with the donation ...

The Global Regulatory Brief provides monthly insights on the latest risk and regulatory developments. This brief was written by Bloomberg’s Regulatory Affairs Specialists. The Commodity Futures ...

Excipients can be described as constituents of a medicine other than the active substance. 1 From a regulatory perspective, in the European Union excipients are defined as “any constituent of a ...

Welcome to the Journal of Regulatory Affairs, featuring in-depth coverage of the EU Artificial Intelligence Act (EU AI Act) as well as articles on engineering safety and effectiveness in drug-device ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Minimal residual disease (MRD) is becoming one of the most important response biomarkers in oncology development. Once viewed primarily as a hematologic endpoint, MRD is now influencing broader ...

What Businesses Should Know About Deconstruction Opportunities in the Coming Weeks St Louis, United States – February 7, 2026 / Deconstruction Development Partners / Valensi Rose PLC provides the ...